Project Number 116 Agency/Funding Organization Alzheimer's Society UK Funding Year 2009 View Full Project Details for Dimebon, a new drug for treatment of Alzheimer’s disease: studies of the mechanisms of disease-modifying action. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator Buchman, Vladimir Principal Investigator First Name Vladimir Principal Investigator Last Name Buchman Awardee Organization Cardiff University Contact PI Country United Kingdom Project Detail FY Overall Cost $204,438 Funding Organization Agency/Funding Organization Alzheimer's Society UK Funding Organization Country United Kingdom
